ZIOPHARM ONCOLOGY INC's ticker is and the CUSIP is 98973P951. A total of 3 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -90.0% | 9,300 | -52.8% | 0.00% | – |
| Q2 2023 | $10 | +25.0% | 19,700 | +43.8% | 0.00% | – |
| Q1 2023 | $8 | -77.8% | 13,700 | -75.9% | 0.00% | – |
| Q4 2022 | $36 | -100.0% | 56,900 | -59.8% | 0.00% | – |
| Q3 2022 | $243,000 | +872.0% | 141,700 | +594.6% | 0.00% | – |
| Q2 2022 | $25,000 | +108.3% | 20,400 | +4.1% | 0.00% | – |
| Q1 2022 | $12,000 | -77.4% | 19,600 | -3.4% | 0.00% | – |
| Q4 2021 | $53,000 | -85.9% | 20,300 | -85.2% | 0.00% | – |
| Q3 2021 | $375,000 | +3.3% | 137,600 | 0.0% | 0.00% | – |
| Q2 2021 | $363,000 | -0.8% | 137,600 | +13416.7% | 0.00% | -100.0% |
| Q1 2021 | $366,000 | +266.0% | 1,018 | +155.1% | 0.00% | – |
| Q4 2020 | $100,000 | -45.9% | 399 | -45.9% | 0.00% | – |
| Q3 2020 | $185,000 | -54.9% | 737 | -41.0% | 0.00% | -100.0% |
| Q2 2020 | $410,000 | +83.9% | 1,250 | +36.8% | 0.00% | – |
| Q1 2020 | $223,000 | -73.4% | 914 | -48.5% | 0.00% | -100.0% |
| Q4 2019 | $838,000 | +45.5% | 1,776 | +31.8% | 0.00% | 0.0% |
| Q3 2019 | $576,000 | -8.4% | 1,348 | +24.8% | 0.00% | 0.0% |
| Q2 2019 | $629,000 | +295.6% | 1,080 | +160.9% | 0.00% | – |
| Q1 2019 | $159,000 | +103.8% | 414 | -1.7% | 0.00% | – |
| Q4 2018 | $78,000 | -60.6% | 421 | -32.2% | 0.00% | -100.0% |
| Q3 2018 | $198,000 | +10.6% | 621 | +4.4% | 0.00% | 0.0% |
| Q2 2018 | $179,000 | -34.9% | 595 | -4.6% | 0.00% | -91.7% |
| Q1 2018 | $275,000 | -14.9% | 624 | -37.0% | 0.01% | -14.3% |
| Q4 2017 | $323,000 | +634.1% | 991 | +193.2% | 0.01% | +600.0% |
| Q3 2017 | $44,000 | +69.2% | 338 | +2.1% | 0.00% | +100.0% |
| Q2 2017 | $26,000 | -54.4% | 331 | -55.5% | 0.00% | -50.0% |
| Q1 2017 | $57,000 | -67.1% | 743 | +28.8% | 0.00% | -80.0% |
| Q4 2016 | $173,000 | -18.0% | 577 | -24.4% | 0.01% | -28.6% |
| Q3 2016 | $211,000 | +38.8% | 763 | +48.2% | 0.01% | +40.0% |
| Q2 2016 | $152,000 | +42.1% | 515 | -9.3% | 0.01% | +11.1% |
| Q1 2016 | $107,000 | +48.6% | 568 | +59.1% | 0.01% | +50.0% |
| Q4 2015 | $72,000 | -59.8% | 357 | -46.6% | 0.01% | -53.8% |
| Q3 2015 | $179,000 | +1391.7% | 668 | +39.7% | 0.01% | +1200.0% |
| Q2 2015 | $12,000 | -50.0% | 478 | +382.8% | 0.00% | -66.7% |
| Q1 2015 | $24,000 | +2300.0% | 99 | +219.4% | 0.00% | – |
| Q4 2014 | $1,000 | – | 31 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 37,200 | $23,436 | 0.00% |
| SIMPLEX TRADING, LLC | 13,700 | $8 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |